Literature DB >> 10604586

Antecedent liver disease and drug toxicity.

S Schenker1, R R Martin, A M Hoyumpa.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10604586     DOI： 10.1016/S0168-8278(99)80325-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  17 in total

1.  Hepatotoxicity in patients with cirrhosis, an often unrecognized problem: lessons from a fatal case related to amoxicillin/clavulanic acid.

Authors:  R J Andrade; M I Lucena; M C Fernández; J L Vega; R Camargo
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 2.  A guide to the management of tuberculosis in patients with chronic liver disease.

Authors:  Radha K Dhiman; Vivek A Saraswat; Harshal Rajekar; Chandrasekhar Reddy; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

3.  A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity.

Authors:  Pedro Zapater; José Such; Miguel Pérez-Mateo; José Francisco Horga
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Drug-physiology interaction and its influence on the QT prolongation-mechanistic modeling study.

Authors:  Barbara Wiśniowska; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-03-15       Impact factor: 2.745

Review 5.  Drug-induced liver injury in older adults.

Authors:  Sarah J Mitchell; Sarah N Hilmer
Journal:  Ther Adv Drug Saf       Date:  2010-12

Review 6.  Antitubercular therapy in patients with cirrhosis: challenges and options.

Authors:  Naveen Kumar; Chandan Kumar Kedarisetty; Sachin Kumar; Vikas Khillan; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

7.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

8.  Age-related changes in the hepatic pharmacology and toxicology of paracetamol.

Authors:  Sarah J Mitchell; Alice E Kane; Sarah N Hilmer
Journal:  Curr Gerontol Geriatr Res       Date:  2011-05-11

9.  Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.

Authors:  Dana D Byrne; Janet P Tate; Kimberly A Forde; Joseph K Lim; Matthew Bidwell Goetz; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Roger Bedimo; Matthew S Freiberg; Amy C Justice; Jay R Kostman; Jason A Roy; Vincent Lo Re
Journal:  Clin Infect Dis       Date:  2017-10-16       Impact factor: 9.079

10.  Case report of acute liver injury caused by the eszopiclone in a patient with chronic liver disease.

Authors:  Tong Wu; Ge Yu; Zhaoxia Li; Guijie Xin
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.